One-year Kaplan-Meier event rates in patients with a CHA2DS2-VASc 0–2 (men) or 1–3 (women) compared with remaining cohort (CHA2DS2-VASc score of ≥3 for men and ≥4 for women)
| Event | CHA2DS2-VASc 0–2 (men) or 1–3 (women) | Remaining cohort |
| All-cause mortality, n (%) | 341 (2.0) | 1226 (5.9) |
| Ischaemic stroke/systemic embolism, n (%) | 128 (0.8) | 345 (1.7) |
| Haemorrhagic stroke/major bleed, n (%) | 67 (0.7) | 199 (1.4) |